SCHEMBL1630165

SCHEMBL1630165

N#Cc1cccc(-n2nccc2-c2ccc(O)cc2O)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NT5E P21589 3/20 0.42
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
GRM5 P41594 4/20 0.38
IRAK4 Q9NWZ3 1/20 0.37
NPBWR1 P48145 1/20 0.37
MCHR1 Q99705 1/20 0.37
NOTUM Q6P988 1/20 0.37
ESR1 P03372 2/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
HSP90AA1 P07900 1/20 0.37
ELANE P08246 1/20 0.36
VCP P55072 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629050 0.88 NR3C2 (0.41) NT5EALDH1A1KDM4EMAPTTSHR
SCHEMBL1628683 0.87 NPBWR1 (0.50) NT5EALDH1A1KDM4EMAPTHTT
SCHEMBL1630056 0.85 POLB (0.46) ALDH1A1MAPTESR1HSP90AA1ELANE
SCHEMBL1628980 0.85 NT5E (0.44) NT5EESR1HSP90AA1
SCHEMBL1630409 0.81 HSP90AA1 (0.51) ALDH1A1MAPTESR1HSP90AA1
SCHEMBL1631556 0.80 ESR1 (0.56) NT5EALDH1A1KDM4ETSHRESR1
SCHEMBL1629817 0.80 ESR1 (0.56) NT5EESR1HSP90AA1
SCHEMBL1629166 0.80 NR3C2 (0.47) NT5EALDH1A1MAPTESR1HSP90AA1
SCHEMBL1630410 0.80 ALDH1A1 (0.40) NT5EALDH1A1KDM4EMAPTTSHR
SCHEMBL1628955 0.77 MEN1 (0.44) ALDH1A1MAPTESR1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP claimed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P NT5E 4734/4885ALDH1A1 777/4885KDM4E 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.